Lakewood-Amedex Biotherapeutics Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -30 | |||
EBITDA | -3,761 | -886 | -681 | -1,868 |
EBIT | -3,761 | -887 | -712 | -1,869 |
Net Income | -3,772 | -923 | -744 | -1,907 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,104 | -349 | -422 | -610 |
Cash | 2,584 | 11 | 236 | 658 |
Basic Shares | 1,419 | 699 | 191 | 1,393 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -3,626 | -4,731 | -8,150 |
EBIT | -3,746 | -4,850 | -8,271 |
Net Income | -3,847 | -4,855 | -8,281 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -1,944 | -5,725 | -6,816 |
Cash | 236 | 681 | 2,529 |
Basic Shares | 1,393 | 699 | 699 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$2.75 |
2026-03-31 | -$1.31 |